:)(@Shitsngiggles_) 's Twitter Profile Photo

In a surprising turn, Amylyx Pharmaceuticals is withdrawing from the market due to lack of efficacy in recent trials. What's next for ALS treatment? 🤔

account_circle
Andrew LaPelusa(@USARMYMD) 's Twitter Profile Photo

Learn how intermediate clinical endpoints can predict overall survival in early-stage breast cancer patients. Valuable insights on adjuvant therapy.
Read more: ift.tt/X4YRZk0

account_circle
Andrew LaPelusa(@USARMYMD) 's Twitter Profile Photo

Exciting news! The DEDICATE-DZHK6 trial reveals that transcatheter aortic valve repair matches up to the surgical approach for low-to-intermediate-risk aortic stenosis patients. Read more about this groundbreaking study here: ift.tt/tPSpxdL.

account_circle
Alpha Bionics(@alpha_bionics) 's Twitter Profile Photo

Peri - implantitis, characterized by inflammation and bone loss around dental implants, poses a considerable risk to implant stability and patient oral health

phatech phabionicstech

Peri - implantitis, characterized by inflammation and bone loss around dental implants, poses a considerable risk to implant stability and patient oral health

#PublicHealth #sistema #HealthcareInnovation #al #HealthAndWellness #MedicalNews #alphatech #alphabionicstech
account_circle
Integral Clinic Solutions(@Integral_soln) 's Twitter Profile Photo

AstraZeneca’s study shows Benralizumab works effectively in children 6-11 years, matching safety profiles in older patients.

Keeping kids safe and healthy! 📊

account_circle
eMedEvents(@eMedEvents) 's Twitter Profile Photo

🔍 Exciting insights on treating left main coronary artery disease!
bit.ly/4cUYsB2

🧪Learn about the innovative DCB-only strategy from a groundbreaking study by Sanna Uskela et al.

Credit: Frontiers

account_circle
BulletinHealthcare(@BulletinHealth_) 's Twitter Profile Photo

and are developing an platform to assist radiologists.

Stay informed by signing up for Healthcare Marketing Daily below!

go.bulletinhealthcare.com/bhc_hmd

Marketing

account_circle